Linical Co., Ltd. (2183.T) JPX

238.00

-2(-0.83%)

Updated at May 14 09:48AM

Currency In JPY

Linical Co., Ltd.

Address

Shin-Osaka Brick Building

Osaka, 532-0003

Japan

Phone

81 6 6150 2478

Website

https://www.linical.co.jp

Sector

Healthcare

Industry

Biotechnology

Employees

662

First IPO Date

October 27, 2008

Key Executives

Name	Title	Pay	Year Born
Kazuhiro Hatano	President, Chief Executive Officer, Chief Strategy Officer, Chief Commercial Officer & Representative Director	0	1965
Keigo Tsujimoto	Executive Officer & Chief Project Officer	0	1964
Masaya Miyazaki	Executive Officer & Chief Asia Pacific Officer	0	1971
Clareece West	President & Chief Commercial Officer of Americas & Europe	0	N/A
Shiori Yamaguchi	Executive Officer & CCO	0	1975
Jun Kawai	Executive Officer & Chief Administrative Officer	0	1968
Satoru Toyota	Executive Officer & Head of Oncology Business Unit (HQ, Japan)	0	N/A
Tokuno Masayoshi	Executive Officer & Chief Information Officer	0	N/A
Toshiaki Nagafuji	Executive Officer, Chief Technology Officer & Head of Innovative Drug Development Business Unit (HQ, Japan)	0	N/A
Tracy Goeken	Chief Medical Officer	0	N/A

Description

Linical Co., Ltd. provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs consultation support, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariat; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical management. The company was incorporated in 2005 and is headquartered in Osaka, Japan.